Latest News about ACAD
Recent news which mentions ACAD
ACADIA Pharmaceuticals Faces Several Price Target Cuts After Q2 Results, But This Analyst Disagrees
August 09, 2022
Tickers
ACAD
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
August 08, 2022
From Benzinga
Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases
August 05, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022
August 05, 2022
From Benzinga
From Benzinga
FDA Asks For Additional Study For Acadia's Pimavanserin In Alzheimer's-Associated Delusions
August 05, 2022
Tickers
ACAD
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
67 Biggest Movers From Yesterday
June 22, 2022
From Benzinga
Tickers
ACAD
From InvestorPlace
Nasdaq Rises 2.5%; ACADIA Pharmaceuticals Shares Plummet
June 21, 2022
From Benzinga
From Benzinga
45 Stocks Moving In Tuesday's Mid-Day Session
June 21, 2022
From Benzinga
U.S. Markets Open Higher; Lennar Earnings Top Views
June 21, 2022
From Benzinga
From Benzinga
10 Biggest Price Target Changes For Tuesday
June 21, 2022
From Benzinga
From Benzinga
71 Biggest Movers From Yesterday
June 16, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
